FeesSafety
Pluang+

Medtronic raised to Buy with $100 target after strong Q1 revenue and $700M investment in Heart Tech.

Analyst Insights
02 Sep 2026, 01:04 WIB
Rayan Ahmad
View Source
Bullish
Medtronic raised to Buy with $100 target after strong Q1 revenue and $700M investment in Heart Tech.

Analyst BTIG upgraded Medtronic to a Buy rating and raised its price target to $100, citing strong Q1 FY2027 revenue of $9.76 billion driven by broad demand. The company is investing over $700 million in Heart Tech and Robotics, signaling a focus on innovation and durable growth. Medtronic also offers a dividend yield above 3%, nearing Dividend King status with 50 years of consecutive dividend increases, attracting long-term investors. This positive outlook supports confidence in Medtronic's leadership in healthcare technology and its financial growth potential.

More News (MDT)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App